CrestPoint Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,500
Closed -$836K 192
2017
Q3
$836K Sell
12,500
-1,400
-10% -$99K 0.37% 92
2017
Q2
$1.08M Buy
+13,900
New +$1.05M 0.51% 68
2016
Q4
Sell
-9,900
Closed -$769K 216
2016
Q3
$769K Sell
9,900
-3,600
-27% -$291K 0.39% 88
2016
Q2
$1.05M Hold
13,500
0.56% 58
2016
Q1
$1.11M Sell
13,500
-100
-0.7% -$8.13K 0.6% 54
2015
Q4
$1.21M Sell
13,600
-600
-4% -$51K 0.69% 44
2015
Q3
$1.09M Sell
14,200
-200
-1% -$16.7K 0.63% 54
2015
Q2
$1.21M Sell
14,400
-1,000
-6% -$88.3K 0.64% 48
2015
Q1
$1.39M Sell
15,400
-400
-3% -$34.4K 0.72% 40
2014
Q4
$1.28M Sell
15,800
-200
-1% -$15.8K 0.69% 40
2014
Q3
$1.2M Buy
16,000
+200
+1% +$14.6K 0.72% 38
2014
Q2
$1.08M Buy
15,800
+2,000
+14% +$136K 0.63% 56
2014
Q1
$966K Buy
+13,800
New +$960K 0.6% 59

Other funds holding CAH

CrestPoint Capital Management's CAH Position: Q4 2017 in Review

CrestPoint Capital Management sold out of Cardinal Health (CAH) in Q4 2017, closing a stake of 12,500 shares — an estimated $836K sold.

CrestPoint Capital Management first reported a position in CAH in Q1 2014 and held it in 13 quarters. The position peaked at $1.39M in Q1 2015. 722 funds tracked by Wall St. Rank hold CAH as of Q4 2017.

  • CrestPoint Capital Management reported no remaining Cardinal Health position as of Q4 2017 after selling out during the quarter.
  • CrestPoint Capital Management sold 12,500 Cardinal Health shares in Q4 2017, an estimated $836K.
  • CrestPoint Capital Management first reported a position in Cardinal Health in Q1 2014 and held it in 13 quarters.
  • CrestPoint Capital Management's Cardinal Health position peaked at $1.39M in Q1 2015.
  • 722 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.